EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Digital pathology‐based artificial intelligence algorithms in prostate cancer: inside the ‘black box’

Claire M de la Calle, Alexander S Baras, Tamara L Lotan iD

BJU International · 2026

DOI: 10.1111/bju.70164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BJU International, 2026. Verfasst von Claire M de la Calle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Artificial Intelligence, Algorithms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) algorithms leveraging digital pathology slides are currently transforming the way urological cancers are diagnosed and graded, and they add additional prognostic, predictive and molecular subtyping information beyond traditional pathological risk stratification. This review explores recent advances in histopathology‐based AI systems for prostate cancer. We examine how these algorithms perform relative to pathologists for tumour diagnosis and grading, and the ways in which they surpass pathologists with respect to reducing inter‐observer variability and providing quantified tumour metrics. We particularly focus on prognostic algorithms that have been benchmarked against ‘gold standard’ patient outcomes such as metastasis or death, and we highlight the emerging role of digital pathology‐enabled AI for predicting response to therapy or underlying tumour molecular alteration status. Finally, we touch on the advantages of, and barriers to, implementation of digital pathology and histopathology‐based AI algorithms in clinical practice. Through this synthesis of current literature, we underscore the emerging potential of AI for standardising pathological assessment, guiding clinical management, and improving patient outcomes in prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsArtificial IntelligenceAlgorithmsHumansMalePrognosisNeoplasm GradingIntelligent Systems

Stichwörter der Autor:innen

artificial intelligencepathologypredictionprognosisprostate cancerwhole slide images

Autor:innen und Institutionen

  • Department of Urology, University of Washington, Seattle, WA, USA.
  • Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.
  • The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

ORCID-Profile: Tamara L Lotan

Zitieren

APA

de la Calle, C. M., Baras, A. S., & Lotan, T. L. (2026). Digital pathology‐based artificial intelligence algorithms in prostate cancer: inside the ‘black box’. BJU International. https://doi.org/10.1111/bju.70164

Vancouver

de la Calle CM, Baras AS, Lotan TL. Digital pathology‐based artificial intelligence algorithms in prostate cancer: inside the ‘black box’. BJU International. 2026. doi:10.1111/bju.70164

BibTeX
@article{delaCalle2026,
  author = {de la Calle, Claire M and Baras, Alexander S and Lotan, Tamara L},
  title = {Digital pathology‐based artificial intelligence algorithms in prostate cancer: inside the ‘black box’},
  journal = {BJU International},
  year = {2026},
  doi = {10.1111/bju.70164}
}
Kostenlos starten →